Señales en vivo de DOMH | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 may 2024 @ 16:00):

Stats
Volumen de hoy	5 934.00
Volumen promedio	12 530.00
Capitalización de mercado	13.12M
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.480
ATR14	$0.0870 (3.75%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-30	Hayes Anthony	Buy	3 482	Common Stock
2024-05-29	Hayes Anthony	Buy	1 158	Common Stock
2024-05-29	Wool Kyle Michael	Buy	5 000	Common Stock
2024-04-08	Wool Kyle Michael	Buy	4 250	Common Stock
2024-04-08	Wool Kyle Michael	Buy	4 250	Common Stock

INSIDER POWER
100.00
Last 61 transactions
Buy: 1 522 838 \| Sell: 0

Dominari Holdings Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dominari Holdings Inc. Finanzas

Annual	2023
Ingresos:	$2.04M
Beneficio Bruto:	$1.60M (78.32 %)
EPS:	$-4.38

FY	2023
Ingresos:	$2.04M
Beneficio Bruto:	$1.60M (78.32 %)
EPS:	$-4.38

FY	2022
Ingresos:	$0
Beneficio Bruto:	$188 000 (0.00 %)
EPS:	$-7.23

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.530

Financial Reports:

No articles found.

Dominari Holdings Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dominari Holdings Inc.

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company\'s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.